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Abstract

Epidermal Growth Factor Receptor Activation by Pseudomonas
aeruginosa Elastase and its Role in Pulmonary Epithelial Injury
Omar J. Castillo
Thesis Chair: Ali Azghani, Ph.D.
The University of Texas at Tyler
Spring 2013

Epithelial permeability is distorted by Pseudomonas aeruginosa elastase (PE)
and changes in barrier function are caused by disruption of tight junction (TJ)
proteins occludin, zonula occludens (ZO)-1 and alterations of the cytoskeleton.
Increase in paracellular permeability is caused, in part, by activation of cellular
signaling transduction pathways. The exact signaling mechanisms that lead to
epithelial disruption are not yet fully understood. I sought to evaluate whether PE
exposure can activate the epidermal growth factor receptor (EGFR) and what
role, it plays in TJ disruption. My results indicate that inhibition of EGFR
attenuated PE induced disruptive changes in expression of TJ proteins occludin
and ZO-1. Elastase also caused morphological changes in TJ proteins within 1
hour. Occludin was translocated from the membrane and ZO-1 was delocalized
from the cellular periphery. Structural changes in TJ proteins correlated with
decreased transepithelial electrical resistance measurements, which is indicative
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of decreased barrier function. I propose that PE induces changes in TJ structure
and function by an EGFR dependent mechanism.
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Chapter One
Introduction
Pseudomonas aeruginosa is a ubiquitous, Gram-negative, opportunistic
bacterium, which can cause acute pneumonia, chronic lung infection and
bronchiectasis in patients with cystic fibrosis (CF). The lack of a vaccine and an
effective long-term antibiotic therapy makes management of this pathogen
incredibly challenging. In CF populations, pulmonary colonization by
Pseudomonas is achieved by numerous events; eminent among them is
inadequate function of mucociliary motility due to viscid dehydrated mucus
secretions, which impair clearance of the bacterium from the lungs [1,2]. In vivo
studies indicate that P. aeruginosa rarely directly adheres to the airway
epithelium [3], instead it preferentially resides as biofilms in CF lungs [1,4], where
it can secrete a number of virulence factors onto the pulmonary epithelium. Thus,
it is likely that these secreted metabolites are responsible for disruption of the
epithelium and subsequent inflammation and edema. Pseudomonas aeruginosa
virulence factors include extracellular toxins that aid in the pulmonary infection;
they include elastase, exotoxin A, exoenzyme S, pyocyanin pigment and several
alkaline proteases [5-8].
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Once pulmonary colonization is achieved, P. aeruginosa perturbs the
integrity of the airway epithelial lining [7] , which relies on an effective cell-cell
and cell-matrix interactions [9] in order to maintain epithelial integrity. One of the
early destructive effects of P. aeruginosa is, its ability to increase paracellular
epithelial permeability to ions and macromolecules [10]. The pulmonary
epithelium consists of a series of junctional complexes, which include: tight
junctions, desmosomes, gap junctions, and adherence junctions, each with a
diverse structure and a unique role [11]. Of particular interest is the furthermost
layer in the epithelium which is composed of tight junction (TJ) proteins, where
they serve as gatekeepers to paracellular permeability and help maintain cell
polarity[12]. Bacterial mediated disruptions in TJ structure and function
compromise physiological and defensive role of the epithelia and facilitate
bacterial systemic dissemination to other tissues [7]. Furthermore, considering
the fact that the basolateral domain of the epithelia is extremely sensitive to
cytotoxins of P. aeruginosa [13], it is inferred that increased epithelial
permeability renders the lungs more susceptible to pulmonary injury [14].
Thus, maintaining the structure and function of TJ proteins is essential to
prevent and if necessary, combat infection. When visualized with free-fracture
electron microscopy this junctional complex appears as a series of independent
sealing strands in pulmonary epithelia [15,16]. Notable TJ complex proteins
include claudins, occludins and several junction adhesion molecules. Prominent
among these are the zonula occludens (ZO-1, ZO-2 and ZO-3) proteins, which
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belong to the family of membrane-associated guanylate kinase homologs [17].
Within these proteins is ZO-1, a 225-kD protein that is found to be localized on
the junctional complex region in a variety of epithelia [18]. Localized ZO-1 in the
cellular periphery is closely associated with functional tight junctions [19]. As for
ZO-1 function, it is a scaffolding/adapting protein that connects perijunctional
actin filaments with transmembrane proteins of TJs, such as occludin [19,20].
The 65-kD transmembrane protein occludin spans the cell four times and
contains two large extracellular COOH-terminal cytoplasmic domains that link to
other occludins on adjacent cells via homophilic interactions [20,21]. Finally,
claudins and occludins seal TJs by making homotypic interactions with
neighboring cells (Figure 1) [21,22]. This dependency of the epithelial cell barrier
upon proteins that have extracellular domains raises the possibility that TJs might
be influenced by external factors that perturb protein structure and/or function.
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Figure 1. Schematic representation of tight junctions proteins. Scaffolding adaptor protein ZO-1 links
the cytoskeleton with the transmembrane protein occludin. Occludin is an essential component of TJs by
linking with itself at the COOH-terminal cytoplasmic domains of adjacent cells.

	
  
One of the key virulence factors in P. aeruginosa infections is the zinc
metalloproteinase elastase (PE) [23]. Pseudomonal elastase, also known as
LasB, has proteolytic activity. It is involved in elastin destruction and induction of
host cell signal transduction events [23-26]. In a gene knockout experiment,
Pseudomonas lacking elastase were found to be less virulent and molecules
cleared more easily from the lungs in mice models, with an observed dosedependent destructive effect [7]. One study demonstrated that PE can induce
protein kinase C (PKC) signaling, an event which resulted in decreased occludin
functionality, leading to tight junction disruption and cytoskeletal alterations [24].
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The molecular mechanisms through which P. aeruginosa accomplishes its
early destructive effects on the epithelial barrier are poorly understood. Studies
have indicated that PE increases paracellular permeability of pulmonary epithelia
by either: cytoskeleton reorganization, depletion, or disconnection of F-actin from
tight junctional proteins [7,24,27]. Others have suggested that disruption of the TJ
complex might occur through activation of the mitogen-activated protein kinase
(MAPK) pathway [26,28]. Since various intracellular signaling pathways are
involved in the assembly, function and integrity of TJs [29-35], it is conceivable
that PE utilizes specific host cells signaling mediators to modulate epithelial
barrier function.
The epidermal growth factor receptor (EGFR) found in the superfamily of
tyrosine kinase receptors is involved in regulation, differentiation and
mitosis[29,30]. It is a transmembrane protein that exists in the plasma membrane
as a monomer; once it is activated it undergoes ligand-induced dimerization,
which leads to phosphorylation of one of several tyrosine kinase cytoplasmic
domains. Activation of these intracellular tyrosine kinase residues can initiate
stimulation of several signaling pathways [31-35]. A previous study from our
laboratory with pulmonary fibroblasts (IMR90) cells demonstrated that PE
phosphorylates tyrosine-1068 with a higher affinity than the rest of the tyrosine
residues. This makes tyrosine-1068 the most likely target for phosphorylation by
PE in Calu-3 cells.
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Tight junctions are associated with various cell membrane and cytosol
components. Their assembly and function are regulated by activation of several
signal transduction pathways [24,36,38]. In vivo exposure of Pseudomonas
elastase will first reach the apical layer [39], where histopathological studies
have found that elastase disrupts the epithelium and increases lung epithelial
permeability [10,25,40]. In vitro studies indicate that PE alters epithelial
permeability by depleting TJ proteins occludin and ZO-1 in a dose and time
dependent manner, however PE exposure does not change claudin expression
[10,24].
I address the hypothesis that disruption of the cytoskeleton and TJ
proteins by Pseudomonas elastase may occur through activation of EGFR and
downstream signal transduction cascade of MAPK. I provide evidence indicating
that alterations of the cytoskeleton and the TJ complex by Pseudomonas
elastase occur through activation of EGFR and downstream signaling of MAPK.
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Materials and Methods
Cell culture
Human bronchial adenocarcinoma epithelial cell lines, Calu-3 (ATCC),
were used as an in vitro model of epithelial cell injury. Calu-3 cells were chosen
due to their well-documented capacity to form tight junctions and their associated
inter-cellular proteins that include occludin and ZO-1; and ability to form
monolayers that are impermeable to ions and macromolecules [37,41]. Cells
were cultured in RPMI-1640 (HyClone, South Logan, UT) and supplemented with
10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 1% Lglutamine (Cellgro, Herndon, VA). Cells were incubated at 37 0C in an
atmosphere of 5% CO2 and maintained with a penicillin (100 U/ml) and
streptomycin (0.1mg/ml) cocktail (BioWhitaker, Walkersville, MD). Cells were
grown in 75cm2 tissue culture flasks (Corning, Corning, NY) and were transferred
at 80% confluency; all experiments were carried out between passage numbers
15-30. For epithelial permeability measurements, cells were seeded at a density
of 1.0 x 105 cells per insert, on a 6.5mm porous, polycarbonate tissue-culture
transwell permeable insert (0.4 µm pore size and 0.33 cm2, Costar, Lowell, MA)
until they formed confluent monolayers. Before treatment, the cells were serum
starved in RPMI-1640 with 1% L-glutamine for 12 hours.
Specific Inhibitors of Cell Signaling Pathways
To demonstrate involvement of EGFR activation and signaling through an
EGFR/MAPK signaling pathway, I utilized a specific EGFR tyrosine kinase
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inhibitor, AG1478 (Calbiochem, La Jolla, CA). A MEK1/2 inhibitor U0126
(Calbiochem, La Jolla, CA) was used to block the activation of the extracellular
signal-regulated kinase (ERK1/2) arm of MAPK signaling pathway [42]. Cells
were pre-treated for 30 minutes with either a 1µM dilution of AG1478 or a 25 µM
dilution of U0126, prior to being exposed to elastase. As a positive control I
treated cells with epidermal growth factor (Sigma, St. Louis, MO) for 1 hour. All
inhibitors were diluted in RPMI-1640 with 1% L-glutamine.
Bacterial Elastase
I utilized purified P. aeruginosa elastase (Elastin Product Co, Owensville,
MO) and applied it apically on Calu-3 monolayers at a concentration of 2 U/mL.
On average a dose of 2 U/mL is found in the lungs of patients infected with P.
aeruginosa based on antigen quantification from sputum samples [27]. Elastase
had its purity and enzymatic activity confirmed using an elastin-fluorescein assay
as directed by the manufacturer.
Transepithelial Electrical Resistance
In order to quantitatively assess changes in paracellular permeability I
measured changes in transepithelial electrical resistance (TER). Changes in TER
were measured with chopstick-like electrodes placed in the apical and basal
domains of confluent monolayers connected to a voltmeter (Millicell ERS,
Billerica, MA). Readings were taken before and during apical treatment of the
monolayers to evaluate their electrical resistance and tight junction integrity.
Electrical resistance was calculated with ohm’s formula R=V x l, where R
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(resistance, Ω) = I (current, Amps) x V (voltage, V) and TER (Ω * cm2) = (Rtotal –
Rblank) x SA where Rtotal is the resistance measured, Rblank is the resistance of the
blank insert without any cells , and SA is the surface area of the inserts.
Experiments were performed after RTotal > 1000 ohms in order to ensure Calu-3
cell monolayers had indeed formed functional tight junctions. Values are reported
as percentage decrease from the baseline values before treatments. Studies
were performed in triplicate.
Gel Electrophoresis and Western blot analysis
To obtain total cell lysate the cells were washed three times in ice cold
PBS and harvested with 100 µl of lysis buffer, freeze-thawed twice and scraped
into microcentrifuge tubes. Lysis buffer was prepared using a base buffer
containing 100mM NaCl, 20mM Tris-Cl pH 7.4, 1%Triton and 15% glycerol,
supplemented with protease inhibitor cocktail (1:100, Calbiochem, Billerica, MA)
and sodium orthovanadate (1:1000). Total cell lysates extracts were centrifuged
at 13,000 rpm x for 20 min at 4 0C. Total protein concentration in samples were
measured at 450 nm using Pierce’s BCA Protein Assay Reagent Kit, and using
bovine serum albumin as standards, samples were read with an AD340
spectrophotometer and analysis software (Beckman Coulter, Brea, CA).
Protein samples were processed with 1:1 laemmlli buffer complemented with
1:10 dichlorodiphenyltrichloroethane (DTT) and heated at 95°C for ten minutes.
The proteins were separated using 12% SDS-PAGE in a Mini-Protean
electrophoresis apparatus (BioRad, Waltham, MA). Each lane was loaded with
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25µg of protein and 10µg of BioRad ladder 161-0318 was used for molecular
weight identification. The gel was then transferred to a 0.45µm nitrocellulose
membrane in a BioRad Western blot criterion cell. The membranes were then
blocked overnight with 5% bovine serum albumin in PBST (PBS, 0.1% Tween
20) at 4 0C. I utilized either beta-acting or ponceau staining as a loading control
by the method of Romero [43]. The appropriate primary antibody dilution of
either: phosphorylated EGFR, phosphorylated ERK 1/2 (CellSignal), Occludin
and ZO-1 (Zyomega) was added for 1 hour at room temperature. Secondary
antibody GAx-HRP (BioRad) was added for 1 hour at room temperature. An
amplification step was performed using a Blot Amplification module (BioRad).
After amplification, colorimetric detection was performed using Opti-4CN
Substrate Kit (BioRad) for 30 minutes. Immunoblots were documented using
UVP GelDoc-IT imaging System (UVP, Upland, CA) and quantified with ImageJ
software (NIH).
Immunofluorescence Microscopy
Confluent monolayers were seeded in 96-well tissue culture plates
(CoStar, Corning, NY) or mounted on chambered slides systems (Lab-Tek,
Rochester, NY) and treated according to the above procedures. After the
experiments were completed, cells were washed three times with PBS and fixed
with 3.7% paraformaldehyde in PBS for 10 minutes at room temperature. Cells
were permeabilized with a 0.1% Triton-X 100 in PBS solution for 5 minutes. After
washing twice with PBS, nonspecific binding sites were blocked with 1% bovine
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serum albumin (BSA) for 30 minutes. Rinsed slides were incubated with Alexa
Fluor 594 Phalloidin (Invitrogen, Camarillo, CA) in a 1% BSA solution in PBS for
20 minutes in the dark at room temperature for f-actin staining. Slides were
washed twice with PBS and incubated at 37°C in the dark with FITC conjugated
mouse anti-occludin (Zymed, Camarillo, CA) or FITC conjugated mouse anti-ZO1 (Promega, Madison, WI) for 60 minutes at 37°C. Following two washes with
PBS, I added a nuclear counterstain, DAPI (4’,6’–di-amidino-2-phenylindole,
Invitrogen, Camarillo, CA) for 5 minutes. The monolayers were examined under
an Olympus fluorescent microscope equipped with an Olympus DP30BW digital
camera (Olympus, Center Valley, PA). Photomicrography was performed under
600x and images were overlayed and pseudocolored (green –occludin, blueactin) for ease of visualization.
Statistical Analysis
Statistical analysis of the differences between the means was performed
with GraphPad Prism 6 (GraphPad Software, San Diego, CA). The results from
TER and relevant band intensities are presented as mean ± 95% confidence
intervals, using either a paired or unpaired Student’s t-test. Probability values (p<
0.05) were considered statistically significant.
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Results
Pseudomonas elastase increases paracellular permeability on polarized Calu-3
cells
I grew polarized epithelia, by seeding Calu-3 cells in transwell permeable
supports. After 8-10 days of incubation, visual inspection indicated that Calu-3
cells had formed monolayers. Comparison of TER before and after PE exposures
indicated a time-dependent increase in paracellular permeability when apical
domains of confluent monolayers were exposed to 2 U/ml of PE. Within 30
minutes, TER values had decreased by 15.53% and after 1 hour a 27.45%
decrease in resistance was observed, which was significantly different compared
to a loss of 0.76% (t=3.072, df= 4, p<0.001), in control monolayers (Figure 2).
After 2 hours of PE treatment, TER values had dropped to 61.27% (t=3.142, df=
4, p<0.001) relative to control. My results indicate that PE induces tight junction
disruption in a time-dependent manner.
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Figure 2. PE disrupts epithelial permeability as measured by TER. Calu-3 monolayers grown in
transwell inserts showed a significant PE-induced decrease in electrical resistance across the cell
membranes. Data presented as Mean ± 95% CI of 4 independent experiments in triplicate wells. * indicates
significant changes in TER at p <0.01 compared with control

Epidermal growth factor receptor inhibition mitigates PE-induced disruption of
epithelial permeability
To investigate whether PE utilizes epidermal growth factor receptor
(EGFR) activation to alter paracellular permeability. For functional assays, the
monolayers were pre-treated with AG1478, a specific EGFR tyrosine kinase
inhibitor (EGFRi) for 30 minutes prior to PE exposure. After 30 minutes of PE
exposure cells treated with EGFRi sustained their integrity- an insignificant 3.55%
decrease in TER. After 1 hour a maximum TER loss of 7.47% was observed,
which was statistically different (t=3.007, df= 4, p<0.05) when compared to
monolayers exposed to PE only (Figure 3). The subsequent TER decline in
EGFRi + PE cells was gradual within the first 90 minutes of exposure, after which
time TER stabilized.

	
  

13	
  

Albeit, EGFRi did not completely prevent PE induced disruption, it did
effectively help maintain high TER values. Overall, PE’s disruptive effects saw an
increase of 19.98% in TER when Calu-3 cells were pre-treated with EGFRi and
then exposed to 1 hour of elastase. Although, I did observe a small but significant
drop in TER in monolayers exposed to EGFRi alone, 10.65% (t=3.159, df= 4,
p<0.05) at the end of a 120-minute experiment. These results suggest that the
observed PE induced increase in paracellular permeability is in part, dependent
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Figure 3. Effects of EGFR inhibition and PE exposure on tight junction integrity as measured by
TER. Cells exposed with AG1478 (EGFRi) for 30 minutes prior to treatment with PE retained high
2
paracellular permeability. TER was measured as Ωxcm and is evaluated as % retention compared to their
pre-treatment resistance. SD bars on EGFRi+PE were removed for clarity. Data presented as Mean ± 95%
CI of 4 independent experiments in triplicate wells. * Indicates significant changes in TER at p <0.01
compared with control, # indicates significant changes in TER p<0.05 compared to PE.
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Pseudomonas elastase activates the epidermal growth factor receptor
In an effort to understand the mechanism of action of PE on EGFRdependent TER alteration, I next investigated the effect of PE on EGFR
phosphorylation. Western blot analysis indicated an increase in tyrosine
phosphorylation of EGFR within 5 minutes of apical exposure of elastase (Figure
4A). I chose this early time point because phosphorylation of EGFR peaks within
the first 10 of stimulation [50], and because I wanted to capture early, PEdependent signaling events. Densitometric analysis of the bands showed a
significant increase (41.78± 12.44 %, t=3.358, df= 4, p<0.05) in phosphorylation
levels when Calu-3 cells were exposed to PE. Furthermore, this PE-induced
increase in EGFR phosphorylation was 6% higher than the phosphorylation state
achieved by EGF (Figure 4B).
The degree of inhibition achieved by EGFRi on PE-phosphorylation was
74.05%, which correlates with an attenuated decrease in permeability (t=5.048,
df= 4, p<0.01) measured by TER. This suggests that PE can activate
downstream signaling pathways mediated by the activity of EGFR tyrosine kinase
phosphorylation.

	
  

15	
  

	
  

* #

200

Control
PE
EGFRi + PE

150

*

100

PE
(2
U
)

PE

EG
FR
i+

on

tr

ol

50

C

Phosphorylation of EGFR (%control)

Figure 4A. PE phosphorylates Epidermal Growth Factor Receptor (EGFR Tyr-1068)
within 5 minutes of apical exposure. Confluent Calu-3 monolayers were treated with 2U
of active Pseudomonas elastase (PE) for 5 minutes. Representative western blot indicating
EGFR activation was mitigated with a 30-minute pre-treatment of AG1478, (EGFR
inhibitor). Experiments were run in triplicate.

	
  
Figure 4B. Densitometric evaluation of phosphorylation of EGFR relative to control
after exposure to 2 U/ml of PE. Densitometric analysis revealed a 35% increase in
protein phosphorylation when Calu-3 cells were exposed to PE for 5 minutes. A tyrosine
kinase inhibitor of EGFR (EGFRi) moderated activation of EGFR by PE. Data are reported
as Mean ± 95% CI. *P<0.05 versus control, #P<0.01, versus EGFRi + PE; n=4.
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Role of EGFR in tight junctional proteins expression
Previous studies have shown that Pseudomonal elastase disrupts
junctional proteins, including the scaffolding protein zonula occludens (ZO)-1
[10,24]. I sought to determine if PE renders its effects on TJ structure through
activation of EGFR. I performed western blot analysis with monolayers after they
had been exposed to 1-hour of PE, probing for total ZO-1 protein.
I detected bands in the 225-kDa regions corresponding to ZO-1 by
western blotting. Exposure to 2 U/mL of PE for 1 hour significantly reduced
(t=17.44, df= 4, p<0.01) ZO-1 protein expression levels by 52.86 ± 3.03 %
(Figure 5B) relative to control which correlates, to TER levels of 72.55% in the
same time period.
In monolayers pre-incubated with EGFRi, I was able to detect 75.10 ±
1.6% of protein relative to control. This represents a conservation of 27.96 ±
3.43% which is a significant (t=8.136, df= 4, p<0.05) conservation of ZO-1 protein
expression during PE treatment (Figure 5B). This reduction in ZO-1 protein loss
parallels maintenance of paracellular permeability since TER values at the same
time point corresponded to readings of 89.01% compared to control.
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Figure 5A. Inhibition of EGFR decreased ZO-1 protein degradation after PE
exposure. Representative western blot analysis after 1-hour exposure to PE using-ZO-1
antibodies on Calu-3 monolayers. Cells maintained in serum free media (lane 1). A marked
decrease in ZO-1 protein levels was observed on cells treated with PE alone (lane 2). Preincubating the monolayers with AG1478 diminished ZO-1 protein loss (lane 3). No change
of ZO-1 expression was observed in cells treated with EGFRi alone (lane 4). Experiments
were run in triplicate.
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Figure 5B. Densitometric analysis of ZO-1 protein levels after exposure to PE,
inhibition of EGFR diminished protein loss. Pre-treatment with an EGFRi maintained
ZO-1 levels at 75.10% relative to control. Data are reported as mean ± 95% CI, # depicts
P<0.05 in EGFRi vs PE, * depicts P<0.01 in PE vs Control; n=4
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EGFR inhibition attenuates PE-induced ZO-1 delocalization
Since the function of ZO-1 is not only determined by its expression but also
by its molecular arrangement, I studied the cellular architecture under
immunofluorescent microscopy to look for any PE-mediated changes.
Immunofluorescence micrographs of control Calu-3 cell monolayers showed a welldefined staining of ZO-1 proteins where it appears localized to the cellular periphery
(Figure 6A). In treated cells the continuous ring of ZO-1 was replaced by punctate
structures with little fluorescence with scattered fluorescent points located in the
cellular periphery and the cytosol. In some areas complete loss of fluorescence was
visualized, even with higher exposure times (Figure 6B). These results suggest that
PE is capable of delocalizing and possibly destroying TJ proteins.
Immunofluorescent microscopy revealed that EGFRi preserved ZO-1
structure and localization, where it presented sharper and brighter bands. The
photomicrographs suggest down-regulation of ZO-1 expression and its localization
at the periphery of the cells is regulated, in part, by EGFR activation (Figure 6C).
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Figure 6. Immunofluorescence microscopy of tight junction protein ZO-1 of Calu-3 cells exposed to
PE. Calu-3 cells were exposed apically to 2U of PE for 1 hour and incubated with FITC-conjugated mouse
anti-ZO-1 post-treatment. A. Control. B. Cells exposed to PE only, exposure time had to be increased in
order to visualize ZO-1. C. Calu-3 monolayers pre-incubated with AG1478 for 30 minutes prior to PE
exposure. The results shown are representative of four independent experiments performed on slides in
duplicate.
Scale bar 10µm
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Inhibition of EGFR retains tight junctional protein occludin expression
I investigated whether high TER values obtained after 1 hour of PE
application by inhibition of EGFR was related to expressional conservation of TJ
protein occludin. I found a time-dependent depletion of occludin proteins in Calu3 monolayers when exposed to PE (2U/mL) [18] (Figure 7A). Statistically
significant changes were observed within 15 minutes of apical PE exposure,
compared to control groups (t=5.056, df= 4, p<0.01). Within 30 minutes occludin
expression in cells that had been treated with PE was 67.91 ± 6.34%, and overall
after 1 hour of PE, occludin had decreased by 72.85 ± 5.39%, compared against
control cells that were kept in serum free media.
Inhibition of EGFRi maintained relatively higher occludin levels. Within 15
minutes occludin was retained 29.79 ± 11% higher (t=19.10, df= 4, p<0.05),
compared against cells that had been treated PE alone (Figure 7B). Occludin
levels were preserved after 1 hour showing 85.94 ± 3.77 % expression, which
suggests that PE induced occludin disruption, requires EGFR activation.
Additionally, observational analysis of western blotting showed various bands or
smudges (2 usually) around the 60-kDa mark in experiments that had been
exposed to PE; thus indicative that perhaps PE changes occludin protein
structure or its phosphorylation state.
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Figure 7A. EGFR inhibition prevents occludin translocation in a time-dependent
manner. Representative immunoblot analysis with antibody against occludin showing
confluent Calu-3 cells exposed to 2U of apical PE. Occludin protein levels decreased heavily
after 30 minutes of PE exposure and rapidly afterwards. Inhibition of EGFR attenuated, but did
not prevent complete occludin protein loss.
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PE. Densitometric analysis of Calu-3 cells after apical exposure to 2U of PE at different
time intervals. Inhibition of EGFR by AG1478 attenuated occludin protein loss in a timedependent manner. After 60 minutes, occludin concentration was 56.15% higher in cells
pre-incubated with EGFRi compared to cells treated with PE alone. Data are reported as
Mean ± 95% CI. #P<0.05 versus PE, *P<0.01, versus control; n=4.
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PE induces translocation of occludin through EGFR activation
As with ZO-1, proper occludin function requires it to be accurately located
on the cellular membrane. Immunofluorescence microscopy of Calu-3
monolayers revealed a strong affinity for FITC-labeled mouse anti-occludin
antibodies. In control cells, occludin was seen aggregating around the periphery
of the cellular membrane with continuous rings forming on the junctions with
neighboring cells (Figure 8A).
I found PE translocated occludin from the cellular membrane and occludin
diffusion was visualized as faint punctate rings. PE treated cells showed
abnormal occludin staining, and revealed a complete loss of junctional rings
formed by occludins of adjacent cells. Occludin morphology was also significantly
altered, as normal occludin rings changed to undulate smeared structures (Figure
8B).
In cells that had undergone EGFR inhibition, retention of occludin staining
and cell shape was visualized, which correlated with brighter
immunofluorescence signals. In some cases, EGFRi treated slides showed that
monolayers retained their junctional rings with neighboring cells (Figure 8C).
Although, it is important to note that EGFRi did not completely prevent PE
induced morphological occludin changes. In some cases punctation was present,
indicative that some level of occludin translocation or diffusion had occurred. The
results suggest that PE is able to modulate epithelial permeability by occludin
translocation from the cellular periphery, in part by EGFR activation.
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Figure 8. Immunofluorescence microscopy images of tight junction protein occludin
exposed to PE. Monolayers were treated for 1 hour with 2U of apical PE and post-treatment
were incubated with FITC-conjugated mouse anti-occludin. A. Control. B. Exposure to PE
resulted in occludin delocalization and pigmentation. C. Pre-treatment with AG1478 maintained
localization of occludin in monolayers and reduced disruption. The results shown are
representative of four independent experiments performed on slides in duplicate.
Scale
bar 10µm
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PE disrupts occludin and ZO-1 colocalization with the cytoskeleton via an EGFR
dependent mechanism
In order for epithelia to function as a defensive barrier, the tight junctions
in the stratum corneum must work together. Tight junction function depends on
the precise interaction between perijunctional proteins linking together with the
actin cytoskeleton [12]. In order to assess if the interaction between ZO-1,
occludin and the actin cytoskeleton is susceptible to morphological change
induced by PE, I looked at fluorescent micrographs after fluorescent labeling
using mouse monoclonal antibodies or Alexa Fluor Phalloidin staining of ZO-1,
occludin and F-actin. Immunofluorescent images where then overlayed using
ImageJ software.
In cells exposed to media only, I observed well defined staining of
occludin, which appeared as a near continuous ring localized to the periphery of
the cell (Figure 9A1). Filamentous actin appeared as numerous bands forming a
ring-like structure that encircled the perijunctional area. Filaments were also
dispersed among the cellular lumen (Figure 9A2). ZO-1 appeared as a bright ring
localized to the cellular membrane (Figure 10A1), which interdigitated with Factin in overlayed images (Figure 10A3). Overlaying occludin and F-actin
micrographs revealed a number of areas with high cell-cell contact had
reinforcing interactions between occludin and F-actin (Figure 9A3).
I detected distinct differences in monolayers that were exposed to PE;
normal cellular morphology was lost in 1 hour, occludin (Figure 9B1) and F-actin
both became disorganized and distorted (Figure 9B2). ZO-1 was delocalized
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from the periphery and in some areas it appeared punctate and blurred (Figure
10B1). In areas that had highly distorted ZO-1, F-actin filaments were barely
discernable and highly disrupted (Figure 10B2). In other experiments using
brightfield illumination, cells exposed to PE detached from the extracellular matrix
and became round and free floating, appearing as holes in the monolayer after
immunofluorescence (Figure 9C1). PE was shown to cause severe disruption of
the actin cytoskeleton. Results show a significant alteration in F-actin
organization as well as reductions in staining intensity at the perijunctional ring
(Figure 9B2). Interactions between occludin with F-actin were harder to visualize,
in part due to changes in the arrangement of the actin cytoskeleton and occludin
morphology (Figure 9B3).
Although inhibition of EGFR did not completely abolish PE-mediated
effects on occludin and ZO-1 colocalization with F-actin, it attenuated the
disruption and loss of colocalization between these proteins. F-actin staining
appeared more prominent and sharp, with clear definition of the perijunctional
ring (Figure 9C2, 10C2). Overlaying images with occludin and F-actin showed a
higher degree of proximity than in monolayers treated with PE alone (Figure
9C3). Taken together, the data implies that PE induced occludin translocation,
ZO-1 delocalization and F-actin disruption are in some part dependent on
signaling stimulated by activation of EGFR.
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Figure 9. Representative photomicrographs of occludin and F-actin obtained by fluorescent
microscopy after exposure to PE. Calu-3 cells were treated to 2U of PE for 1 hour, cells were then
incubated with FITC conjugated anti-occludin (green) and Alexa 488 Phalloidin for F-actin (red). Overlayed
images (last column) show marked decrease in colocalization of f-actin with occludin as well as loss of factin corresponding to changes in cellular morphology (middle column). The results shown are
representative of four independent experiments performed on slides in duplicate.
Scale bar 10µm
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Figure 10. Representative photomicrographs of ZO-1 and F-actin obtained by immunofluorescence
of Calu-3 cell monolayers after exposure to PE. Calu-3 cells were exposed apically to 2U of PE for 1
hour, after which they were fixed and stained with Alexa 488 Phalloidin selective for F-actin (red) and FITC
labeled mouse anti-ZO-1 (green). A1-A3 control cells exposed to serum-free media. B1-B3, cells treated
with PE show decline in F-actin and ZO-1 proteins as well as corresponding morphological changes. C1-C3,
cells pre-treated with AG1478 show attenuated ZO-1 loss as well as diminishing F-actin protein disruption.
The results shown are representative of four independent experiments performed on slides in duplicate.
Scale bar 10µm
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Discussion
The pulmonary epithelium has evolved to function as a protective barrier
against invasion by microorganisms and their metabolites. Tight junction
formation between adjacent epithelial cells prevents passage of microbes and
their toxins across the apical layer and into the basolateral domain [45].
Disruption of this protective barrier by bacterial elastase is a critical step in
Pseudomonas infection [7] as it allows the bacterium to access the lung
parenchyma and cause interstitial pneumonia and systemic infection and
inflammation [13,46].
In this study, I utilized Calu-3 pulmonary epithelial cells as an in vitro
model to determine what effects PE exposure has on barrier function and TJ
structure. Calu-3 cells have a unique advantage provided by the fact that when
they are grown in transwell inserts they form polarized monolayers containing
tight junctions. Due to this cellular behavior, these cells have been used as a
model of pulmonary epithelial barrier function [24,43,46].
The present study shows that PE mediates EGFR activation, which
precedes changes in TJ structure and function. Western blotting indicates PE
induced down-regulation of occludin and ZO-1 protein expression. A stark PEmediated increase in paracellular permeability was associated with the
disassembly of tight junctional proteins ZO-1, occludin and F-actin as observed
via immunofluorescence microscopy and corresponding TER data.
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The TER data implies that the destructive effects Pseudomonas elastase
exerts on epithelial permeability are not just the consequences of elastolytic
activity, but rather a combination of enzymatic and host signaling mechanisms
that affect the epithelia in adverse ways. Maintaining high transepithelial electrical
resistance by inhibiting EGFR during PE exposure, suggests that PE is capable
of activation or transactivation of EGFR and downstream signaling mechanisms
that lead to TJ disruption. Measured increases in paracellular permeability
induced by PE, are in accordance with previous experiments performed with
Pseudomonal elastase on polarized epithelial monolayers [10,24].
Interestingly, while inhibition of EGFR attenuated TER loss induced by PE,
activation of EGFR by EGF slightly increased TER levels in a time-dependent
manner. Suggesting that these two contrasting effects might be mediated by
activation of different intracellular signaling pathways (Figure 1). Several studies
show that polarized epithelia differ in the amount of EGF receptors found in the
apical and basolateral domains and activation of these receptors lead to different
downstream signaling pathways [53]. Normally the EGF receptor is
predominantly localized to the basolateral surface in most epithelial cell lines[5457], yet several hundred EGFR receptors per cell are located on the apical
surface of epithelial cells [46,58]. Previous experiments had shown that TER
values increase with exposure of exogenous apical EGF [59], and decreased
with apical PE application [7,10,24], application of these molecules induced
phosphorylation of EGFR. Densitometric analysis in my setup demonstrated that
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PE was able to activate EGFR with marginally higher levels than human EGF
indicating that differences measured were a result of either activation
mechanisms of EGF receptors or antibody selection bias. For instance I noticed
that PE has a higher affinity to 1068 than other tyrosine residues, whereas
human EGF activates all tyrosine residues.
The differences observed in paracellular permeability could be caused by
different downstream signaling mechanisms. A recent study, involving MAPK
signaling using Calu-3 cells demonstrated for the first time that tight junctions in
monolayers could be disrupted by cytokines [43]. Clark et al, have demonstrated
that PE induces changes in PKC activation in Calu-3 cells. Increased PKC
activation preceded TJ disruption through similar methods, loss of occludin and
ZO-1 expression and localization. Clarke et al, also found that PE did not mediate
these effects through proteolytic effects, since no discernable tight junctional
proteins were found in the concentrated supernatant [24]. PKC-dependent
pathways have been found to mediate TJ permeability induced by a variety of
pathogens. One study found that Helicobacter pylori mediated activation of PKC,
which led to TJ disruption [60]. Since several intracellular signaling pathways are
influenced by both PKC and EGFR, it is possible that TJ disruption is induced by
a combination of these effects [40,61,62]. In intestinal Caco-2 monolayers,
inhibition of PKC activity attenuated TER increase induced by exogenous EGF
application [63]. It is possible that cross-talk between EGFR and PKC signaling
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may be an important mechanism used by Pseudomonas to mediate infection and
invasion of pulmonary epithelia.
Tight junctional complexes are characterized by their junctional plasticity in
terms of their quick ability to disassociate and reconstruct themselves, an
essential process to normal cellular function [58]. Alteration of this process,
however, may result in TJ disassembly and a subsequent increase in cellular
permeability. The dramatic depletion (-72%) observed in western blots of TJ
protein after 1 hour of PE exposure and the immunofluorescence observations
revealing punctate structures replacing occludin suggest that TJ function should
be compromised. However, a sharp drop in TER was not detected. It is likely that
occludin disruption results in a limited amount of TER loss due to its partial
regulatory role in tight junction function.
Recent reports indicate that occludin expression is not required in TJ
formation in several epithelial tissue types including intestinal and sertoli cells
[65,66]. Experiments with a mice gene-knockout model showed that claudin took
over the role of occludin in TJ formation [67]. Another investigation suggested
that occludin disruption does not induce claudin disturbance nor is it indicative of
claudin protein loss [68]. In my study, I decided to disregard claudin expression
or localization since previous results from our lab had determined that PE does
not affect the fate of claudin.
I detected a loss of ZO-1 expression and found it dislocated from the
cellular periphery. These deviations from normality were correlated with an
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increase in paracellular permeability as measured by TER. ZO-1 functions as a
scaffolding protein whose role is to link occludin to the actin cytoskeleton[18].
Even though filamentous actin is one of the most abundant proteins found
in the cytoskeleton, its small size and resilience to degradation makes it difficult
to measure small alterations. At present, one of the best techniques used to
evaluate changes in F-actin is the highly specific, mushroom-derived toxin,
phalloidin. This specific probe is useful because it recognizes filamentous actin
but not free actin monomers [63]. Visualized filamentous F-actin provides insight
into the fate of this protein during PE exposure.
Although intracellular signaling events can dictate function and localization
of TJ proteins, they themselves must communicate in order to coordinate their
structure. Occludin is normally found at high levels of phosphorylation at several
serine and threonine residues. Conversely during disruption of tight junctions
occludin primarily phosphorylate tyrosine residues in the C-terminal domain,
which weakens its association with ZO-1[64,65]. Recently it was found that
occludin tyrosine phosphorylation and disruption activates the extrinsic pathway
of apoptosis in mammary (EpH4) epithelial cells [62,66]. Elastase may be
capable of inducing similar effects through TJ signaling or by its mechanical
disruption [67]
In conclusion, the results from this study indicate that Pseudomonal
elastase is capable of quickly activating EGFR resulting in a novel mechanism
through which it achieves increasing permeability in the pulmonary epithelium. As
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for molecular mechanisms of this phenomenon, I noted that reductions in
occludin and ZO-1 protein expression correlate with decreasing TER values. I
observed occludin translocation from the cellular membrane, delocalization of
ZO-1 from the cellular periphery and a high degree of cytoskeletal reorganization
due to the mediation by PE-induced EGFR activation
.
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Abstract

Pseudomonas aeruginosa Elastase Disruption of Tight Junctions
via MAPK Signaling Pathway
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Spring 2013
Pseudomonas aeruginosa elastase (PE) is able to mediate pulmonary epithelial
permeability, mainly by disrupting tight junction (TJ) function and structure.
Previous studies have shown that PE induces several cellular responses
including activation of protein kinase C (PKC) and the epidermal growth factor
receptor (EGFR). The exact mechanism of epithelial disruption is not fully
understood. The aim of this study was to determine if PE-induced TJ disruption
was dependent upon activation of the extracellular signal-regulated kinases
(ERK) arm of the mitogen-activated protein kinase (MAPK) pathway. I
demonstrate that PE induces phosphorylation of ERK proteins within 5 minutes of
apical exposure. Activation of MAPK preceded a loss of localization of TJ
proteins occludin and zonula occludens (ZO)-1 and cytoskeletal reorganization.
Furthermore, I propose that TJ disruption is elicited, in part, by activation of
EGFR/MAPK signaling pathway by Pseudomonas elastase.
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Chapter Two
Introduction
Pseudomonas aeruginosa is an opportunistic pathogen with a high
intrinsic ability to resist common antibiotics [1]. This bacterium causes community
acquired pneumonia and patients in critical care units frequently acquire P.
aeruginosa induced ventilator-associated fatal pneumonia [2,3].
Furthermore, P. aeruginosa causes recurrent pulmonary infection in cystic
fibrosis (CF) lungs, a common inherited disease among Caucasians [4,7]. In CF
lungs, P. aeruginosa almost always mutates into a mucoidal strain, a phenotype
that resists host immune systems and destruction by antibiotics [4-6]. Conversion
to mucoid phenotype and formation of biofilm community in CF lungs enables P.
aeruginosa to resist eradication and permanently colonize the lungs [8-10]. One
of the initial putative destructive effects of P. aeruginosa is increased epithelial
paracellular permeability, an event accomplished by disrupting tight junctions (TJ)
[11,12]. Once multiprotein tight junctional complexes are disrupted, bacterial
dissemination and potential systemic infection will follow [13]. An in vitro study
using polarized cell monolayers indicated that cytotoxicity increased once P.
aeruginosa gained access to the basolateral membrane [14]
Thus it is assumed that increased epithelial permeability accelerates
morbidity and mortality of a P. aeruginosa pulmonary infection [1-5].
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Several virulence factors and secreted proteolytic enzymes including
elastase aid P. aeruginosa in disrupting TJs [5,15-18]. Pseudomonas elastase
(PE) is a metalloprotease with a wide variety of effects, spanning from
destruction of elastic tissue in the lungs, degradation of innate and adaptive
immune components to initiating adverse host signaling pathways [12,15,19-22].
Bacteria lacking elastase are less virulent in acute as well as chronic models of
pulmonary infection [13,23,24].
Previously I determined that P. aeruginosa elastase activates the
epidermal growth factor receptor (EGFR) in Calu-3 monolayers. Activation of
EGFR can have diverse results on TJ function [25-28]. Various secondary
messenger systems are activated by EGFR, including the mitogen-activated
protein kinase (MAPK) pathway, inositol trisphosphate (IP3) kinase pathway, Akt
and the diacylglycerol (DAG) kinase pathway (Figure 1.) [25,29,30]. Azghani et
al, reported that PE activates MAPK pathway intermediates in pulmonary
fibroblasts and in primary rabbit alveolar type ll cells [31]. Since various signaling
pathways regulate the function and integrity of TJs, it is conceivable that PE
utilizes specific intracellular host cells signals to modulate epithelial barrier
function.
Activation of the MAPK signaling cascade is associated with transcription
and translation of genes that are involved in the regulation of the cell cycle [3234]. A significant body of evidence suggests that TJ disruption might occur
through activation of the MAPK pathway in response to various stressors
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[28,31,35]. In human colorectal epithelial cells (Caco-2) exposed to hydrogen
peroxide, it was found that occludin, ZO-1 and their interactions with the actin
cytoskeleton were mediated via MAPK signaling [36]. Activation of MAPK
pathway mediated tight junction disassembly in 2 other bronchial epithelial cell
lines, BEAS-2B and 16HBE14o, when they were exposed to cigarette smoke
[37]. In Calu-3 monolayers cytokines induced tight junctions disruption by
transactivation of EGFR and signaling through the extracellular signal-regulated
kinase (ERK) 1/2 arm of MAPK pathway. The authors detected phosphorylated
ERK levels within 5 minutes by western blot analysis and observation of TJ
proteins with confocal microscopy showed that occludin and ZO-1 were no longer
colocalized [28].
In an effort to dissect the signaling mechanisms by which PE induces TJ
disruption, I looked at the signaling pathways activated by EGFR. Clark et al,
demonstrated that PKC is activated in PE-mediated TJ disruption [21]. Another
potential signaling pathway shared by EGFR/PKC is the MAPK signaling
pathway[25]. The purpose of this study was to investigate whether increased
epithelial permeability induced by elastase, requires activation of MAPK signaling
cascade.
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Figure 1. Schematic representation of several signaling pathways activated by the epidermal growth
factor receptor [25]. Numerous signaling mechanisms are activated by phosphorylation of EGFR tyrosine
kinase domains.
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Materials and Methods
Cell culture
Human bronchial adenocarcinoma epithelial cell lines, Calu-3 (ATCC),
were used as an in vitro model of epithelial cell injury. Calu-3 cells form tight
junctions impermeable to ions and macromolecules [38,39]. Cells were cultured
in RPMI-1640 (HyClone, South Logan, UT) and supplemented with 10% fetal
bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 1% L-glutamine
(Cellgro, Herndon, VA). Cells were then incubated at 37 0C in an atmosphere of
5% CO2 and maintained with a penicillin (100 U/ml) and streptomycin (0.1mg/ml)
cocktail (BioWhitaker, Walkersville, MD). Cells were grown in 75cm2 tissue
culture flasks (Corning, Corning, NY) and were transferred at 80% confluency; all
experiments were carried out between passage numbers 15-30. For epithelial
permeability measurements, cells were seeded at a density of 1.0 x 105 cells per
insert, on a 6.5mm porous, polycarbonate tissue-culture transwell permeable
insert (0.4 µm pore size and 0.33 cm2, Costar, Lowell, MA) until they formed
confluent monolayers. Before treatment, the cells were serum starved in RPMI1640 with 1% L-glutamine for 12 hours.
Specific Inhibitors of Cell Signaling Pathways
To demonstrate the involvement of EGFR activation and signaling through
an EGFR/MAPK signaling pathway, I utilized an EGFR tyrosine kinase inhibitor
AG1478 (Calbiochem, La Jolla, CA). A MEK1/2 inhibitor U0126 (Calbiochem, La
Jolla, CA) was used to block the activation of the extracellular signal-regulated
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kinase (ERK1/2) arm of MAPK signaling pathway [40]. Cells were pre-treated for
30 minutes with either a 1µM dilution of AG1478 or a 25 µM dilution of U0126,
prior to being exposed to elastase. As a positive control I treated cells with
epidermal growth factor (Sigma, St. Louis, MO) for 1 hour. All inhibitors were
diluted in RPMI-1640 with 1% L-glutamine.
Bacterial Elastase
I utilized purified P. aeruginosa elastase (Elastin Product Co, Owensville,
MO) to understand the cellular and molecular mechanisms involved in TJ
disruption. Elastase applied it apically on Calu-3 monolayers at a concentration of
2 U/mL. On average a dose of 2 U/mL is found in the lungs of patients infected
with P. aeruginosa based on antigen quantification from sputum samples [19].
Elastase had its purity and enzymatic activity confirmed using an elastinfluorescein assay as recommended by the manufacturer.
Transepithelial Electrical Resistance
In order to quantitatively assess changes in paracellular permeability I
measured changes in transepithelial electrical resistance (TER). Changes in TER
were measured with chopstick-like electrodes placed in the apical and basal
domains of confluent monolayers connected to a voltmeter (Millicell ERS,
Billerica, MA). Readings were taken before and during apical treatment of the
monolayers to evaluate their electrical resistance and tight junction integrity.
Electrical resistance was calculated with ohm’s formula R=V x l, where R
(resistance, Ω) = I (current, Amps) x V (voltage, V) and TER (Ω * cm2) = (Rtotal –
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Rblank) x SA where Rtotal is the resistance measured, Rblank is the resistance of the
blank insert without any cells , and SA is the surface area of the inserts.
Experiments were performed after RTotal > 1000 ohms in order to ensure Calu-3
cell monolayers had indeed formed functional tight junctions. Values are reported
as percentage decrease from the baseline values before treatments. Studies
were performed in triplicate.
Gel Electrophoresis and Western blot analysis
To obtain total cell lysate the cells were washed three times in ice cold
PBS and harvested with 100 µl of lysis buffer, freeze-thawed twice and scraped
into microcentrifuge tubes. Lysis buffer was prepared using a base buffer
containing 100mM NaCl, 20mM Tris-Cl pH 7.4, 1%Triton and 15% glycerol,
supplemented with protease inhibitor cocktail (1:100, Calbiochem, Billerica, MA)
and sodium orthovanadate (1:1000). Total cell lysates extracts were centrifuged
at 13,000 rpm x for 20 min at 4 0C. Total protein concentration in samples were
measured at 450 nm using Pierce’s BCA Protein Assay Reagent Kit, and using
bovine serum albumin as standards, samples were read with an AD340
spectrophotometer and analysis software (Beckman Coulter, Brea, CA).
Protein samples were processed with 1:1 laemmlli buffer complemented with
1:10 dichlorodiphenyltrichloroethane (DTT) and heated at 95°C for ten minutes.
The proteins were separated using 12% SDS-PAGE in a Mini-Protean
electrophoresis apparatus (BioRad, Waltham, MA). Each lane was loaded with
25µg of protein and 10µg of BioRad ladder 161-0318 was used for molecular
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weight identification. The gel was then transferred to a 0.45µm nitrocellulose
membrane in a BioRad Western blot criterion cell. The membranes were then
blocked overnight with 5% bovine serum albumin in PBST (PBS, 0.1% Tween
20) at 4 0C. I utilized either beta-acting or ponceau staining as a loading control
by the method of Romero [41]. The appropriate primary antibody dilution of
either: phosphorylated ERK 1/2 (CellSignal), Occludin and ZO-1 (Zyomega) was
added for 1 hour at room temperature. Secondary antibody GAx-HRP (BioRad)
was added for 1 hour at room temperature. An amplification step was performed
using a Blot Amplification module (BioRad). After amplification, colorimetric
detection was performed using Opti-4CN Substrate Kit (BioRad) for 30 minutes.
Immunoblots were documented using UVP GelDoc-IT imaging System (UVP,
Upland, CA) and quantified with ImageJ software (NIH).
Immunofluorescence Microscopy
Confluent monolayers were seeded in 96-well tissue culture plates
(CoStar, Corning, NY) or mounted on chambered slides systems (Lab-Tek,
Rochester, NY) and treated according to the above procedures. After the
experiments were completed, the cells were washed three times with PBS and
fixed with 3.7% paraformaldehyde in PBS for 10 minutes at room temperature.
Cells were then permeabilized with 0.1% Triton-X 100 in PBS solution for 5
minutes. After washing twice with PBS, nonspecific binding sites were blocked
with 1% bovine serum albumin (BSA) for 30 minutes. Rinsed slides were
incubated with Alexa Fluor 594 Phalloidin (Invitrogen, Camarillo, CA) in a 1%
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BSA solution in PBS for 20 minutes in the dark at room temperature for f-actin
staining. Slides were then washed twice with PBS after which they were
incubated at 37°C with FITC conjugated mouse anti-occludin (Zymed, Camarillo,
CA) or FITC conjugated mouse anti-ZO-1 (Promega, Madison, WI) for 60
minutes at 37°C in the dark. Following two washes with PBS, I added a nuclear
counterstain DAPI (4’,6’–di-amidino-2-phenylindole, Invitrogen, Camarillo, CA) for
5 minutes and washed with PBS. The monolayers were examined under an
Olympus fluorescent microscope equipped with an Olympus DP30BW digital
camera (Olympus, Center Valley, PA). Photomicrography was performed under
600x and images were overlayed and pseudocolored (green –occludin, blueactin) for ease of visualization.
Statistical Analysis
Statistical analysis of the differences between the means was performed
with GraphPad Prism 6 (GraphPad Software, San Diego, CA). The results from
TER and relevant band intensities are presented as mean ± 95% confidence
intervals, using either a paired or unpaired Student’s t-test. Probability values
(p<0.05) were considered statistically significant.
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Results
In vitro physiological assay displays Pseudomonas aeruginosa elastase induced
increase in paracellular permeability
I measured PE induced changes on Calu-3 monolayers by measuring
changes in transepithelial electrical resistance (TER). Exposing the model to 2
U/mL of PE showed a significant (t=3.072, df= 4, p<0.01) decrease of 15.53% in
TER readings within 30 minutes. A substantial 27.45% loss in resistance was
observed after 60 minutes, which was followed by a gradual but steady TER loss.
After 2 hours TER had decreased by 38.73%, which was significant when
compared to control wells in serum free media (t=3.142, df= 4, p<0.001) (Figure
2).
I sought to determine if PE engaged MAPK pathway activation as a
mechanism to disruption epithelial integrity. I chemically inhibited MEK 1/2 with
UO126 (ERKi) to prevent activation of ERK 1/2 proteins of MAPK pathway.
Subsequent exposure of monolayers to PE did not alter their TER as the
monolayers preserved over 90% of their TER values within the first hour of PE
exposure. At 2 hours post PE-exposure, epithelial permeability readings were
maintained at 83.51%, which was significantly (t=3.38, df= 4, p<0.01) higher than
that of cells treated with PE alone (Figure 2). Quality assurance data indicated
that application of ERKi had no adverse effects on TER in my model. Taken
together, the results showed that PE induced TJ disruption is mainly dependent
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on ERK 1/2 activation; and imply that MAPK signaling plays a role in
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Figure 2. Inhibition of MAPK attenuated Pseudomonas elastase (PE) induced disruption of tight
junction integrity as measured by TER. Calu-3 human lung cells cultured in permeable inserts. Cells
pretreated with the specific kinase inhibitor (ERKi,U0126) for 30 minutes retained high paracellular
2
permeability when exposed to PE. TER was measured as Ωxcm and is evaluated as % retention compared
to their pre-treatment resistance values. Data presented as Mean ± 95% CI of 3 independent experiments in
triplicates, *P <0.01 compared to control cells, #P<0.05 compared to PE-treated monolayers.
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Phosphorylation of the MAPK pathway by Pseudomonas elastase
Since inhibition of key proteins of the MAPK pathway preserved tight
junctions function assessed by TER, I studied the phosphorylation status of ERK
proteins in the MAPK pathway. Western blot analysis of ERK 1/2 indicated that
PE induced phosphorylation of these proteins in serum-starved Calu-3 cells,
within 5 minutes of apical application (Figure 3A). Densitometric analysis of the
protein bands blotted onto the membrane revealed that PE enhanced
phosphorylation of ERK 1/2, by 127.4 ± 3.34% (t=8.114, df= 4, p<0.05) relative to
cells maintained in medium alone, as measured by densitometric analysis (Figure
3B). Inhibiting phosphorylation of ERK 1/2 with the MEK inhibitor U0126 prior to
PE exposure, decreased the level of activated ERK 1/2 by decreased by 42.03 ±
11.13%, (t=3.77, df= 4, p<0.05).
To clarify the relationship between EGFR activation and MAPK signaling
induced by PE, I looked at expression levels of activated ERK 1/2 proteins of the
MAPK signaling pathway in the presence of EGFR inhibitor AG1478 (EGFRi). In
monolayers that had undergone EGFR inhibition prior to PE exposure I detected
a 33.35 ± 7.92% decrease in expression of PE-induced phosphorylated ERK 1/2,
(t=4.21, df= 4, p<0.05). These data indicate the PE activates the ERK
intermediate protein of MAPK signaling pathway through receptors of epidermal
growth factor.
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Figure 3A. Representative western blot analysis of confluent Calu-3 monolayers
exposed for 5 minutes to 2 U/mL of PE.
Activation of EGFR by PE, induces
phosphorylation on Extracellular Signal-Regulated Kinases (ERK) 1/2 within 5 minutes.
Pre-incubation with a MEK inhibitor (ERKi – U0126) or an EGFR inhibitor (AG1478)
attenuated activation by PE.

	
  
Figure 3B. Quantification of phosphorylation levels of ERK 1/2 protein in response to PE. Activation
of the MAPK pathway occurred within 5 minutes of apical exposure to PE. Pre-incubation of Calu-3 cells with
specific inhibitors of the EGFR or MAPK pathway (EGFRi and ERKi) attenuated the level of PE-induced ERK
1/2 phosphorylation. Data are reported as Mean ± 95% CI. *P<0.05 compared with control, # P<0.05
compared with EGFR and MEK Inhibitor + PE.	
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PE-induced downregulation of ZO-1 expression is mediated by MAPK signaling
To understand the mechanism of PE induced ZO-1 disruption I studied the
role of MAPK signaling in maintaining ZO-1 protein integrity. In cells preincubated with an ERKi, ZO-1 levels were maintained at 66.26 ± 3.78%, which is
on average a significant (t=3.947, df= 4, p<0.05) increase of 19.13 ± 4.84%
compared to cells treated with PE only (Figure 4B). Pre-treatment with ERKi was
not significantly different from control, indicating the inhibitor had no adverse
effect.
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Figure 4A. Inhibition of EGFR and ERK decreased ZO-1 protein loss in Calu-3 cell lysates
after PE exposure. Representative western blot analysis after 1-hour exposure to PE using-ZO-1
antibodies on Calu-3 monolayers. A marked decrease in ZO-1 protein levels was observed on
cells treated with PE alone. Pre-incubating the monolayers with AG1478 or U0126 diminished ZO1 protein loss. Experiments were run in triplicate.
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Figure 4B. Densitometry of ZO-1 protein expression after exposure to PE, inhibition of
ERK diminished protein loss. Data are reported as mean ± 95% CI #P<0.05 inhibitors
versus PE, *P<0.01, PE versus Control; n=3

Inhibition of MAPK maintains localization of ZO-1 at the plasma membrane
during PE exposure
Immunofluorescence microscopy was utilized to investigate effects of PE
induced MAPK activation on ZO-1 localization and cell morphology.
Immunofluorescence micrographs probed with anti-ZO-1 antibodies revealed in
control monolayers a distinct localization of ZO-1 protein assembly at the cellular
periphery in control monolayers (Figure 5A). Fluorescence signal was strong and
ZO-1 was easily distinguishable.
Loss of protein was observed as punctation of ZO-1 in cells treated with
PE for 1 hour (Figure 5B). Some cell-cell contact areas showed complete loss of
ZO-1 protein even with higher exposure times, a strong indicator of TJ disruption.
PE-induced reduction in ZO-1 protein expression was attenuated by inhibition of
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ERK 1/2 phosphorylation with U0126. A marked improvement in protein
expression and localization in these cells was observed compared to cells treated
with PE alone (Figure 5C). Inhibition of the MAPK activation diminished
destructive effects of PE.
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Figure 5.Immunofluorescence micrographs of tight junction protein ZO-1 of Calu-3 monolayers after
exposure to PE (2 U/mL) for 1 hour. A. Control monolayers grown on chambered slides. B. PE treated
cells arrows indicates areas where cell-cell contact was disrupted. C. Inhibition of MAPK by U0126
maintains ZO-1 protein expression and localization. The results shown are representative of three
independent experiments performed in duplicates.
Scale bar 10µm. 600x.
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PE mediated dislocation of occludin is dependent on MAPK signaling
I utilized FITC-conjugated mouse anti-occludin antibodies to determine the
effects of PE on occludin expression and localization. In control chambers,
occludin was localized to the cellular membrane where it formed continuous
distinct rings at the junctions of adjacent cells (Figure 6A). I could neither detect
disruptions in occludin nor observe any changes in cellular morphology under
immunofluorescence or brightfield illumination. Treatment with PE for 1 hour
showed alterations in occludin localization. This was observed as faint staining
and smudged or indistinct occludin fluorescence throughout the membrane. Loss
of protein in the membrane was also observed, as punctate structures replaced a
continuous peripheral ring. Homotypic interactions with neighboring cells were
lost and abnormal occludin morphology was prominent throughout the monolayer
(Figure 6B).
Inhibition of the MAPK pathway significantly attenuated PE-induced
disruption of occludin expression and organization (Figure 6C). Clearer staining
with typical, spherical occludin distribution was observed. The junctional rings
formed between adjacent cells were faint but still present. At times however,
interspersed occludin was visualized through the cell membrane, indicating some
degree of TJ disruption, which corresponds to decreased TER values.
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Figure 6. Immunofluorescence micrographs of tight junction protein occludin of Calu-3 cells
exposed to elastase for 1 hour. A. Control monolayers cultured on chamber tissue culture slides B.
Monolayers exposed to 2U/mL of PE. C. Cells pre-treated with U0126, a specific MEK inhibitor prior to PE.
The results shown are representative of three independent experiments performed in duplicates.
Scale bar 10µm. 600x
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PE decreases colocalization of occludin and ZO-1 with the actin cytoskeleton
A key defensive feature provided by TJs is the delicate balance of
interdigitation between the cytoskeleton, ZO-1 and occludin [51]. In order to
assess how MAPK-induced PE signaling disrupts TJs, I grew Calu-3 monolayers
as described earlier, and stained F-actin fibers using Alexa Fluor 488 Phalloidin.
In control cells the F-actin cytoskeleton was observed as a circumferential band
around the cells with numerous filaments interdigitated within the cell membrane
(Figure 7A2). The sharp immunofluorescence F-actin filaments were robust
(Figure 8A2) and found to colocalize with both ZO-1 (Figure 8A3) and occludin
rings (Figure 7A3). This event correlated with high levels of TER indicating
increased tight junction function.
Taken together, I found ZO-1 (Figure 8B1) and F-actin (Figure 8B2) to be
heavily distorted by PE in my in vitro model. A decrease in occludin fluorescence
signal (Figure 7B1) indicated protein translocation from the cellular membrane;
which showed atypical occludin and cytoskeletal disruption (Figure 7B2). In
overlayed images a drastic reduction in colocalization between ZO-1 and the
cytoskeleton was attributed to PE effects (Figure 8B3). In addition, there was little
or no interaction between occludin and F-actin in PE-treated monolayers (Figure
7B3).
To determine if PE mediated these morphological changes through MAPK
signaling, I pre-treated monolayers with an ERKi for 30 minutes prior to PE
exposure. These cells exhibited retained F-actin staining (Figure 7C2). A high
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degree of intracellular interdigitation of filamentous actin was also noticeable
(Figure 8C2). Proximal localization of occludin with the cytoskeleton was clearer
than in cells treated with PE alone (Figure 8C3). ZO-1 was found localized to the
cellular periphery where it appeared to colocalize with F-actin. These data clearly
indicate that PE mediates delocalization of TJ proteins through ERK 1/2.
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Figure 7. Representative micrographs obtained by immunofluorescence staining of occludin and Factin. Green staining represents occludin, red staining represents F-actin and overlayed images of both
occludin and F-actin are presented (last column). A1 – A3 control cells. B1-B3 cells exposed to 2U/mL of PE
for 1 hour. C1-C3 PE exposure in ERKi pretreated cells. The results shown are representative of four
independent experiments performed on slides in duplicate.
Scale bar 10µm. 600x.
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Figure 8. Representative fluorescent micrographs of ZO-1 and F-actin during PE exposure. Green
staining represents ZO-1 (first column), red staining represents F-actin (middle column) and overlayed
images of both ZO-1 and F-actin are presented in the last column. A1 – A3 control cells. B1-B3 cells
exposed to 2U/mL of PE for 1 hour. C1-C3 PE exposure of ERKi pretreated cells. The results shown are
representative of four independent experiments performed on slides in duplicate.
Scale bar 10µm.
600x.
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Discussion
The present study shows that Pseudomonas elastase is capable of
activating mitogen-activated protein kinase (MAPK) signaling pathway. Activation
of this pathway was associated with increased paracellular permeability as
measured by changes in TER. Alterations in localization and interactions of TJ
proteins ZO-1, occludin and F-actin were mediated by a PE-induced MAPK
signaling mechanism. Furthermore I found that ERK 1/2 phosphorylation
coincides with EGFR activation, suggesting the involvement of PE-induced
EGFR/MAPK signaling pathways in TJ disruption.
Activation of MAPK has been associated with cell cycle events, which
includes mitosis, differentiation, motility and gene expression as well as cellular
apoptosis. Recently several studies have found that tight junctions are intimately
associated with MAPK signaling [28,36,37,44-47]. One study with bronchial
epithelial cell lines established that cigarette smoke induces ZO-1 delocalization
by ERK 1/2 activation [37]. Knockdown of ERK by siRNA enhanced tight junction
integrity and accelerated monolayer formation in undifferentiated epithelial
colorectal cells [44]. When corneal epithelial cells were exposed to phorbol 12myristate 13-acetate (PMA), tight junction disruption occurred via activation of
ERK, an effect that was attenuated by pretreating monolayers with an inhibitor of
MAPK signaling [48]. Studies with two cell lines of different origin (bronchial Calu3 and intestinal Caco-2 monolayers) indicated that TJ disruption is mediated by
EGFR induced MAPK activation when they were exposed to cytokines and bile
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acids, respectively [26,28].
Our lab has shown that PE is capable of mediating MAPK activation in
pulmonary fibroblasts (IMR90) and in primary alveolar type II epithelial cells. In
both studies, MAPK activation was associated with an increase production of
interleukin-8 (IL-8), a hallmark of pulmonary inflammation [31]. Increased IL-8
levels have also been associated with changes in TJ structure [28]. In intestinal
epithelial cells (T-84), Campylobacter jejuni activates ERK phosphorylation and
induces IL-8 secretion to the basolateral domain. The authors indicated that
these events may contribute to TJ disruption [49]. In terms of PE-induced
signaling and epithelial permeability, Clark et al indicated that PKC activation
precedes destructive effects on the pulmonary epithelium [21]. PKC has been
shown to strongly regulate TJ assembly and mediate the correct localization of
several zonula occludens junctional proteins [50]. In support of my findings,
several PKC isoforms have been shown to modulate ERK activity and produce
changes in TJs induced by mediators other than PE [51-53].
A recent study demonstrated that inhibition of EGFR modulates activation
of the MAPK pathway by cytokines in polarized epithelial monolayers, ERK
moderated the fate of TJ proteins [28]. It is therefore plausible, that PE mediates
TJ disassociation by a similar EGFR/MAPK signaling mechanism. Visual
comparison between ERK and EGFR inhibited monolayers indicate that EGFRi
cells retained more junctional proteins and the F-actin cytoskeleton presented
increased interdigitation with both ZO-1 and occludin proteins during PE
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exposure. This suggests that perhaps EGFR activation by PE is inducing
signaling through multiple pathways that aid Pseudomonas in its pathogenesis.
Additionally, my results demonstrate ERK activation is not completely dependent
on EGFR phosphorylation, implying that other signaling mechanisms are involved
in mediating PE-induced ERK 1/2 phosphorylation. It is conceivable that such
signaling pathways as nuclear-factor kappa B, PKC, DAG and Akt may
participate in PE-induced increases in paracellular epithelial permeability.
Taken together, I report that EGFR phosphorylation by PE induces ERK
1/2 activation. Monolayers that had undergone pre-treatment with an ERKi
(U0126) retained TER after1 hour of PE exposure. This observation is partly
attributed to conservation of occludin and ZO-1 localization as visualized by
immunofluorescence microscopy. In ERKi treated cells, the ZO-1 perijunctional
ring showed successful colocalization with the actin cytoskeleton and unlike PE
treated cells, occludin was not translocated from the cellular membrane as it
occurred in PE treated cells. On occasion, however, occludin was visualized as
punctate circular structures in ERK inhibited, PE treated monolayers. My results
clearly indicate P. aeruginosa elastase mediates tight junctional changes through
EGFR/MAPK signaling pathways.
Future research includes investigations to determine whether
Pseudomonas elastase initiates occludin phosphorylation and mediates tight
junction protein signaling; activation of occludin regulates tight junction structure
and apoptosis. Additionally, we would like to discover the crosstalk between PE-
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induced host signaling pathways and their role in pathogenesis of Pseudomonas
aeruginosa in an effort to combat this devastating human pathogen.
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